Report cover image

Veterinary Molecular Diagnostic Market by Product (Instruments & Software, Kits & Reagent, Services), Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction), Animal Type, Disease Indication, End User - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 198 Pages
SKU # IRE18451480

Description

Veterinary Molecular Diagnostic Market by Product (Instruments & Software, Kits & Reagent, Services), Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction), Animal Type, Disease Indication, End User - Global Forecast 2024-2030


The Veterinary Molecular Diagnostic Market size was estimated at USD 579.74 million in 2023 and expected to reach USD 632.40 million in 2024, at a CAGR 9.17% to reach USD 1,071.85 million by 2030.

Global Veterinary Molecular Diagnostic Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Molecular Diagnostic Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Molecular Diagnostic Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Molecular Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Biochek BV, Biomedica Medizinprodukte GmbH, BioMérieux SA, Bioneer Corp, HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., Novacyt Group, Quality Vet Lab, Randox Laboratories, Ltd., Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Molecular Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Instruments & Software
Kits & Reagent
Services
Technology
DNA Sequencing
Microarrays
Polymerase Chain Reaction
Animal Type
Companion Animal
Canine

Equine

Feline
Livestock Animal
Bovine

Ovine or Caprine

Porcine

Poultry
Disease Indication
Diarrhea Pathogens Detection
Respiratory Pathogens Detection
Vector Borne Diseases
End User
Hospitals
Reference Laboratories
Veternary Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Veterinary Molecular Diagnostic Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Molecular Diagnostic Market?
3. What are the technology trends and regulatory frameworks in the Veterinary Molecular Diagnostic Market?
4. What is the market share of the leading vendors in the Veterinary Molecular Diagnostic Market?
5. Which modes and strategic moves are suitable for entering the Veterinary Molecular Diagnostic Market?

Note: PDF & Excel + Online Access - 1 Year

Table of Contents

198 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Veterinary Molecular Diagnostic Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Improving veterinary care facilities in economies
5.1.1.3. Rising incidence of chronic diseases in animals
5.1.2. Restraints
5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
5.1.3. Opportunities
5.1.3.1. Advances in veterinary molecular diagnostic technology
5.1.3.2. Growing availability of pet insurance
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Veterinary Molecular Diagnostic Market, by Product
6.1. Introduction
6.2. Instruments & Software
6.3. Kits & Reagent
6.4. Services
7. Veterinary Molecular Diagnostic Market, by Technology
7.1. Introduction
7.2. DNA Sequencing
7.3. Microarrays
7.4. Polymerase Chain Reaction
8. Veterinary Molecular Diagnostic Market, by Animal Type
8.1. Introduction
8.2. Companion Animal
8.3.1. Canine
8.3.2. Equine
8.3.3. Feline
8.3. Livestock Animal
8.4.1. Bovine
8.4.2. Ovine or Caprine
8.4.3. Porcine
8.4.4. Poultry
9. Veterinary Molecular Diagnostic Market, by Disease Indication
9.1. Introduction
9.2. Diarrhea Pathogens Detection
9.3. Respiratory Pathogens Detection
9.4. Vector Borne Diseases
10. Veterinary Molecular Diagnostic Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Reference Laboratories
10.4. Veternary Clinics
11. Americas Veterinary Molecular Diagnostic Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Veterinary Molecular Diagnostic Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Biochek BV
15.1.2. Biomedica Medizinprodukte GmbH
15.1.3. BioMérieux SA
15.1.4. Bioneer Corp
15.1.5. HealthGene Corporation
15.1.6. Heska Corporation
15.1.7. IDEXX Laboratories, Inc.
15.1.8. Novacyt Group
15.1.9. Quality Vet Lab
15.1.10. Randox Laboratories, Ltd.
15.1.11. Thermo Fisher Scientific, Inc.
15.1.12. VCA, Inc.
15.1.13. Veterinary Molecular Diagnostics Inc.
15.1.14. Virbac S.A.
15.1.15. Zoetis Inc.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2023 VS 2030
FIGURE 3. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
FIGURE 7. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
FIGURE 12. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 14. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us